Figure 1.
Multiple adjusted cumulative incidence curve of any first MOF following initiation of alendronate or denosumab (primary analysis). (A) All subjects. (B) Females. (C) Males.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.